mtmt
Magyar Tudományos Művek Tára
XML
JSON
Átlépés a keresőbe
In English
Principles and Experimental Considerations for In Vitro Transporter Interaction Assays
Bhoopathy, S. ✉
;
Bode, C.
;
Naageshwaran, V.
;
Weiskircher-Hildebrandt, E.
;
Mukkavilli, V.
;
Hidalgo, I.J.
Angol nyelvű Könyvfejezet (Könyvrészlet) Tudományos
Megjelent:
Jose M. Segui-Simarro. Doubled Haploid Technology. (2021) ISBN:9781071613146; 9781071613153
pp. 339-365
Azonosítók
MTMT: 32131520
DOI:
10.1007/978-1-0716-1554-6_13
WoS:
000707185700016
Scopus:
85111890846
PubMed:
34272701
Drug transporters are universally acknowledged as important determinants of the absorption, distribution, metabolism, and excretion of both endogenous and exogenous compounds. Altered transporter function, whether due to genetic polymorphism, DDIs, disease, or environmental factors such as dietary constituents, can result in changes in drug efficacy and/or toxicity due to changes in circulating or tissue levels of either drugs or endogenous substrates. Prediction of whether and to what extent the biological fate of a drug is influenced by drug transporters, therefore, requires in vitro test systems that can accurately predict the risk and magnitude of clinical DDIs. While these in vitro assessments appear simple in theory, practitioners recognize that there are multiple factors that can influence experimental outcomes. A better understanding of these variables, including test compound characteristics, test systems, assay formats, and experimental design, will enable clear, actionable steps and translatable outcomes that may avoid unnecessary downstream clinical engagement. This chapter will delineate the role of these variables in improving in vitro assay outcomes. © 2021, Springer Science+Business Media, LLC, part of Springer Nature.
Idézett közlemények (1)
Hivatkozás stílusok:
IEEE
ACM
APA
Chicago
Harvard
CSL
Másolás
Nyomtatás
2025-04-24 11:00
×
Lista exportálása irodalomjegyzékként
Hivatkozás stílusok:
IEEE
ACM
APA
Chicago
Harvard
Nyomtatás
Másolás